These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36061235)

  • 1. Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis.
    Yin Y; Xu ZY; Liu YJ; Huang W; Zhang Q; Li JP; Zou X
    J Hepatocell Carcinoma; 2022; 9():885-900. PubMed ID: 36061235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic splicing abnormalities induced by DEAD-Box Helicase 56 amplification in colorectal cancer.
    Kouyama Y; Masuda T; Fujii A; Ogawa Y; Sato K; Tobo T; Wakiyama H; Yoshikawa Y; Noda M; Tsuruda Y; Kuroda Y; Eguchi H; Ishida F; Kudo SE; Mimori K
    Cancer Sci; 2019 Oct; 110(10):3132-3144. PubMed ID: 31390121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
    Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
    Front Surg; 2022; 9():836080. PubMed ID: 35392063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
    Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
    Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Analysis of DEAD-Box Helicase 56: A Potential Oncogene in Osteosarcoma.
    Zhu C; Zhang X; Kourkoumelis N; Shen Y; Huang W
    Front Bioeng Biotechnol; 2020; 8():588. PubMed ID: 32671031
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
    Hu B; Yang XB; Sang XT
    Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions.
    Zheng Q; Yang Q; Zhou J; Gu X; Zhou H; Dong X; Zhu H; Chen Z
    Cancer Cell Int; 2021 Jun; 21(1):330. PubMed ID: 34193146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
    Rao B; Li J; Ren T; Yang J; Zhang G; Liu L; Wang H; Huang M; Ren Z; Yu Z
    Front Cell Dev Biol; 2021; 9():686547. PubMed ID: 34350180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma.
    Chen X; Lin L; Chen G; Yan H; Li Z; Xiao M; He X; Zhang F; Zhang Y
    Front Oncol; 2022; 12():900671. PubMed ID: 35814441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy.
    Chen ZD; Luo JY; Ye YP; Dang YW
    Transl Cancer Res; 2023 May; 12(5):1210-1231. PubMed ID: 37304539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Hub Genes Associated With Hepatocellular Carcinoma Using Robust Rank Aggregation Combined With Weighted Gene Co-expression Network Analysis.
    Song H; Ding N; Li S; Liao J; Xie A; Yu Y; Zhang C; Ni C
    Front Genet; 2020; 11():895. PubMed ID: 33133125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis and experimental verification of the prognostic and biological significance mediated by fatty acid metabolism related genes for hepatocellular carcinoma.
    Zhu XR; Zhu JQ; Chen YF; Liu YY; Lu JJ; Sun J; Peng SQ; Chen MB; Du YP
    Front Oncol; 2022; 12():972744. PubMed ID: 35982956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead DEAD/H box helicase biomarkers with the therapeutic potential identified by integrated bioinformatic approaches in lung cancer.
    Cui Y; Hunt A; Li Z; Birkin E; Lane J; Ruge F; Jiang WG
    Comput Struct Biotechnol J; 2021; 19():261-278. PubMed ID: 33425256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
    Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
    Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics Analysis Combined With Experiments Predicts PUDP as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Through Its Interaction With Tumor Microenvironment.
    Yu J; Zhang W; Ding D; Hu Y; Guo G; Wang J; Han Y
    Front Oncol; 2022; 12():830174. PubMed ID: 35350563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification.
    Ke K; Chen G; Cai Z; Huang Y; Zhao B; Wang Y; Liao N; Liu X; Li Z; Liu J
    Cancer Manag Res; 2018; 10():5291-5302. PubMed ID: 30464626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients.
    Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Gao W; Yu X
    Int J Biol Sci; 2022; 18(1):360-373. PubMed ID: 34975338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.